ANCA-associated vasculitis in patients with primary Sjögren's syndrome: Detailed analysis of 7 new cases and systematic literature review

Autoimmunity Reviews

Volumn 14, Issue 8, 2015, Pages 742-750

  Guellec, Dewi ^a   Cornec Le Gall, Emilie ^b   Groh, Matthieu ^c   Hachulla, Eric ^d   Karras, Alexandre ^e   Charles, Pierre ^f   Dunogué, Bertrand ^c   Abad, Sébastien ^g   Alvarez, Fernand ^h   Gérard, Fréderic ^a   Devauchelle Pensec, Valérie ^a,i   Pers, Jacques Olivier ⁱ   Puéchal, Xavier ^c   Guillevin, Loïc ^c   Saraux, Alain ^a,i   Cornec, Divi ^a,i  

^a CHRU Brest   (France)

^b Service de Néphrologie   (France)

^c Institut Cochin   (France)

^d UNIV LILLE   (France)

^e HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^f INSTITUT MUTUALISTE MONTSOURIS   (France)

^g AVICENNE HOSPITAL   (France)

^h Centre Médico Chirurgical de Kourou   (French Guiana)

ⁱ Universite de Brest   (France)

Author keywords

ANCA; ANCA associated vasculitis; Sj gren's syndrome

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CREATINE KINASE; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; RITUXIMAB;

ADULT; AGED; ANCA ASSOCIATED VASCULITIS; ANEMIA; BLOOD CELL COUNT; CHONDRITIS; CHRONIC URTICARIA; CLINICAL ARTICLE; CLINICAL EVALUATION; COMPUTER ASSISTED TOMOGRAPHY; CRYOGLOBULINEMIA; DISEASE SEVERITY; DRUG MEGADOSE; ELECTROMYOGRAM; ELECTROPHORESIS; EOSINOPHILIC GRANULOMA; FEMALE; FOLLOW UP; HEALTH SURVEY; HEMICOLECTOMY; HEMOPERITONEUM; HEMORRHAGIC SHOCK; HOSPITALIZATION; HUMAN; HUMAN TISSUE; HYPERGAMMAGLOBULINEMIA; IMMUNOSUPPRESSIVE TREATMENT; INGUINAL LYMPH NODE; KERATOCONJUNCTIVITIS SICCA; KIDNEY FUNCTION; LABORATORY TEST; LEG EDEMA; LEUKOCYTOCLASTIC VASCULITIS; LOW DRUG DOSE; LYMPHADENOPATHY; MALE; MEDICAL HISTORY; MEDICAL RECORD; MICROSCOPIC POLYANGIITIS; MIDDLE AGED; MINOR SALIVA GLAND; MUSCLE BIOPSY; MYALGIA; NECROTIZING ARTERITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAAORTIC LYMPH NODE; PARESTHESIA; PLASMAPHERESIS; RAYNAUD PHENOMENON; REMISSION; REVIEW; SIALOADENITIS; SJOEGREN SYNDROME; SKIN BIOPSY; SKIN DEFECT; TREATMENT DURATION; WEGENER GRANULOMATOSIS; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; COMPLICATION; HUMANS; IMMUNOLOGY; KIDNEY DISEASES; PROGNOSIS; SJOGREN'S SYNDROME;

ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; HUMANS; KIDNEY DISEASES; PROGNOSIS; SJOGREN'S SYNDROME;

EID: 84930764531     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2015.04.009     Document Type: Review

References (39)

1. Guellec D., Cornec D., Jousse-Joulin S., Marhadour T., Marcorelles P., Pers J.-O., et al. Diagnostic value of labial minor salivary gland biopsy for Sjögren's syndrome: a systematic review. Autoimmun Rev 2013, 12:416-420.
2. Ramos-Casals M., Brito-Zerón P., Solans R., Camps M.-T., Casanovas A., Sopeña B., et al. Systemic involvement in primary Sjögren's syndrome evaluated by the EULAR-SS disease activity index: analysis of 921 Spanish patients (GEAS-SS Registry). Rheumatology 2014, 53:321-331.
3. Baldini C., Pepe P., Quartuccio L., Priori R., Bartoloni E., Alunno A., et al. Primary Sjögren's syndrome as a multi-organ disease: impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients. Rheumatology 2014, 53:839-844.
4. Carvajal Alegria G., Guellec D., Devauchelle-Pensec V., Saraux A. Is there specific neurological disorders of primary Sjögren''s syndrome?. Joint Bone Spine. 2015, 82:86-89.
5. Cornec D., Devauchelle-Pensec V., Tobón G.J., Pers J.-O., Jousse-Joulin S., Saraux A. B cells in Sjögren's syndrome: from pathophysiology to diagnosis and treatment. J Autoimmun 2012, 39:161-167.
6. Youinou P., Pers J.-O. Primary Sjögren's syndrome at a glance today. Jt Bone Spine Rev Rhum 2015, 82:75-76.
7. Shiboski S.C., Shiboski C.H., Criswell L.A., Baer A.N., Challacombe S., Lanfranchi H., et al. American College of Rheumatology classification criteria for Sjögren's syndrome: a data-driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance cohort. Arthritis Care Res 2012, 64:475-487.
8. Cornec D., Saraux A., Pers J.-O., Jousse-Joulin S., Marhadour T., Roguedas-Contios A.-M., et al. Diagnostic accuracy of blood B-cell subset profiling and autoimmunity markers in Sjögren's syndrome. Arthritis Res Ther 2014, 16:R15.
9. Ramos-Casals M., Nardi N., Brito-Zerón P., Aguiló S., Gil V., Delgado G., et al. Atypical autoantibodies in patients with primary Sjögren syndrome: clinical characteristics and follow-up of 82 cases. Semin Arthritis Rheum 2006, 35:312-321.
10. Ramos-Casals M., Solans R., Rosas J., Camps M.T., Gil A., Del Pino-Montes J., et al. Primary Sjögren syndrome in Spain: clinical and immunologic expression in 1010 patients. Medicine (Baltimore) 2008, 87:210-219.
11. Jennette J.C., Falk R.J., Bacon P.A., Basu N., Cid M.C., Ferrario F., et al. 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides. Arthritis Rheum 2013, 65:1-11.
12. Iaccarino L., Gatto M., Bettio S., Caso F., Rampudda M., Zen M., et al. Overlap connective tissue disease syndromes. Autoimmun Rev 2013, 12:363-373.
13. Vitali C., Bombardieri S., Jonsson R., Moutsopoulos H.M., Alexander E.L., Carsons S.E., et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002, 61:554-558.
14. Böttinger E.P., Niles J.L., Collins A.B., McCluskey R.T., Arnaout M.A. Antineutrophil cytoplasmic autoantibody-associated vasculitis presenting as Sjögren's syndrome. Arthritis Rheum 1992, 35:1373-1376.
15. Guillot X., Solau-Gervais E., Coulon A., Debiais F. Sjögren's syndrome with ANCA-associated crescentic extramembranous glomerulonephritis. Jt Bone Spine Rev Rhum 2009, 76:188-189.
16. Hernández J.L., Rodrigo E., De Francisco A.L., Val F., González-Macías J., Riancho J.A. ANCA-associated pauci-immune crescentic glomerulonephritis complicating Sjögren's syndrome. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc 1996, 11:2313-2315.
17. Kamachi M., Migita K., Tominaga M., Ichinose Y., Nakamura H., Origuchi T., et al. Sjögren's syndrome complicated by MPO-ANCA positive crescentic glomerulonephritis. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc 1999, 14:1033-1034.
18. Karargyris G., Stamatopoulos K., Kittas C., Loukopoulos D., Vaiopoulos G. Sjögren's syndrome co-existing with limited Wegener's granulomatosis. Rheumatol Oxf Engl 2000, 39:805-806.
19. Kawashiri S.-Y., Tamai M., Yamasaki S., Nakamura H., Kakugawa T., Sakamoto N., et al. A case of Sjögren syndrome with pulmonary amyloidosis complicating microscopic polyangiitis. Mod Rheumatol Jpn Rheum Assoc 2011, 21:646-650.
20. Rodríguez-Muguruza S., Holgado S., Olivé A. Pulmonary hyalinizing granuloma associated with Sjögren syndrome and ANCA MPO vasculitis. Jt Bone Spine Rev Rhum 2015, 82:71-72.
21. Sato Y., Sakamoto S., Kotajima F., Hashimoto K., Inoue Y., Muramatsu H., et al. A case of Sjögren's syndrome with Wegener's granulomatosis-like pulmonary involvement. Allergol Int 2005, 54:339-342.
22. Shavit L., Grenader T. Clinical manifestations and outcome of ANCA-related pauci-immune glomerulonephritis in patients with Sjögren's syndrome. Clin Exp Rheumatol 2014, 32:S19-S25.
23. Shimizu S., Nakamura Y., Togawa Y., Kamada N., Kambe N., Matsue H. Erythema elevatum diutinum with primary Sjögren syndrome associated with IgA antineutrophil cytoplasmic antibody. Br J Dermatol 2008, 159:733-735.
24. Tatsumi H., Tateno S., Hiki Y., Kobayashi Y. Crescentic glomerulonephritis and primary Sjögren's syndrome. Nephron 2000, 86:505-506.
25. Wang W.-J., Wu H.-S., Chu T.-S. Anti-neutrophil cytoplasmic antibody-associated Pauci-immune crescentic glomerulonephritis complicating Sjögren's syndrome. J Formos Med Assoc Taiwan Yi Zhi 2011, 110:473-477.
26. Yazisiz V., Ozbudak I.H., Nizam I., Erbasan F., Avci A.B., Ozbudak O., et al. A case of primary Sjögren's syndrome with pulmonary-limited Wegener's granulomatosis. Rheumatol Int 2010, 30:1235-1238.
27. Young C., Hunt S., Watkinson A., Beynon H. Sjögren's syndrome, cavitating lung disease and high sustained levels of antibodies to serine proteinase 3. Scand J Rheumatol 2000, 29:267-269.
28. Ienopoli S., Carsons S.E. Extraglandular manifestations of primary Sjögren's syndrome. Oral Maxillofac Surg Clin N Am 2014, 26:91-99.
29. ter Borg E.-J., Risselada A.P., Kelder J.C. Relation of systemic autoantibodies to the number of extraglandular manifestations in primary Sjögren's Syndrome: a retrospective analysis of 65 patients in the Netherlands. Semin Arthritis Rheum 2011, 40:547-551.
30. Alberici F., Martorana D., Bonatti F., Gioffredi A., Lyons P.A., Vaglio A. Genetics of ANCA-associated vasculitides: HLA and beyond. Clin Exp Rheumatol 2014, 32:S90-S97.
31. Burbelo P.D., Ambatipudi K., Alevizos I. Genome-wide association studies in Sjögren's syndrome: what do the genes tell us about disease pathogenesis?. Autoimmun Rev 2014, 13:756-761.
32. Konstantinov K.N., Ulff-Møller C.J., Tzamaloukas A.H. Infections and antineutrophil cytoplasmic antibodies: triggering mechanisms. Autoimmun Rev 2015, 14:201-203.
33. Noel N., André C., Bengoufa D., Dehoulle C., Mahler M., Limal N., et al. Performance evaluation of three assays for the detection of PR3-ANCA in granulomatosis with polyangiitis in daily practice. Autoimmun Rev 2013, 12:1118-1122.
34. Radice A., Bianchi L., Sinico R.A. Anti-neutrophil cytoplasmic autoantibodies: methodological aspects and clinical significance in systemic vasculitis. Autoimmun Rev 2013, 12:487-495.
35. Nishiya K., Chikazawa H., Hashimoto K., Miyawaki S. Antineutrophil cytoplasmic antibody in patients with primary Sjögren's syndrome. Clin Rheumatol 1999, 18:268-271.
36. Font J., Ramos-Casals M., Cervera R., Bosch X., Mirapeix E., García-Carrasco M., et al. Antineutrophil cytoplasmic antibodies in primary Sjögren's syndrome: prevalence and clinical significance. Br J Rheumatol 1998, 37:1287-1291.
37. Merkel P.A., Polisson R.P., Chang Y., Skates S.J., Niles J.L. Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease. Ann Intern Med 1997, 126:866-873.
38. Ziakas P.D., Poulou L.S., Thanos L. Towards integrating positron emission tomography for work-up of patients with Sjögren's syndrome and associated lymphomas. Autoimmun Rev 2014, 13:327-329.
39. Soussan M., Abisror N., Abad S., Nunes H., Terrier B., Pop G., et al. FDG-PET/CT in patients with ANCA-associated vasculitis: case-series and literature review. Autoimmun Rev 2014, 13:125-131.